Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Smecta

Phase 1Small molecule

1

Indications

4

Total Trials

1

Active Trials

0

Competitors

Clinical

Trials by Indication[1]

Effectiveness2 trials

Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children

Completed· Ipsen logo

Ipsen·Phase 3·NCT00352716·300 enrolled

Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and Children

Completed· Ipsen logo

Ipsen·Phase 3·NCT00352989·302 enrolled

Diarrhea1 trial

A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population

Not yet recruiting·—·Phase 1·NCT06588036·100 enrolled

Treatment1 trial

Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults

Completed· Ipsen logo

Ipsen·Phase 4·NCT02704091·858 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Smecta. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Smecta compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Smecta. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ipsen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: Ipsen

Related News